Jasper Therapeutics (JSPR) Total Non-Current Liabilities (2019 - 2026)
Jasper Therapeutics (JSPR) recorded Total Non-Current Liabilities of $7.85 million in Q2 2026, down 62.1% from $20.7 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Jasper Therapeutics reported Total Non-Current Liabilities of $15.46 million, down 2.9% from FY2024.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -23.2% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $15.93 million in FY2024 (+12.2%), $14.19 million in FY2023 (+41.6%), $10.02 million in FY2022 (-45.5%) and $18.39 million in FY2021 (-68.2%).
- The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2019.
- On a year-over-year basis, Total Non-Current Liabilities rose in four of the last seven quarters, with growth averaging 17.7%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 82.3% in Q2 2025, against a decline of 92.4% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Jasper Therapeutics | 14.34 Mn | -112.08 Mn | - | 7.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.85 Mn |
| Dec 31, 2025 | 13.20 Mn |
| Sep 30, 2025 | 21.01 Mn |
| Jun 30, 2025 | 20.70 Mn |
| Mar 31, 2025 | 13.09 Mn |
| Dec 31, 2024 | 15.93 Mn |
| Sep 30, 2024 | 13.47 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Mar 31, 2024 | 10.47 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 13.98 Mn |
| Jun 30, 2023 | 11.65 Mn |
| Mar 31, 2023 | 11.23 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 10.84 Mn |
| Jun 30, 2022 | 9.64 Mn |
| Mar 31, 2022 | 9.96 Mn |
| Dec 31, 2021 | 17.75 Mn |
| Sep 30, 2021 | 18.02 Mn |
| Jun 30, 2021 | 139.22 Mn |
API Access
Jasper Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();